These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 6308972

  • 1. Effectiveness of ethylketocyclazocine in hemorrhagic shock.
    Curtis MT, Lefer AM.
    Adv Shock Res; 1983; 10():101-9. PubMed ID: 6308972
    [Abstract] [Full Text] [Related]

  • 2. Actions of opiate antagonists with selective receptor interactions in hemorrhagic shock.
    Curtis MT, Lefer AM.
    Circ Shock; 1983; 10(2):131-45. PubMed ID: 6301706
    [Abstract] [Full Text] [Related]

  • 3. Beneficial actions of nalorphine during hemorrhagic shock in cats.
    Hock CE, Curtis MT, Jaffe JS, Lefer AM.
    Proc Soc Exp Biol Med; 1983 May; 173(1):76-81. PubMed ID: 6304745
    [Abstract] [Full Text] [Related]

  • 4. Beneficial action of a new opiate antagonist (Win 44,441-3) in hemorrhagic shock.
    Curtis MT, Lefer AM.
    Eur J Pharmacol; 1982 Mar 12; 78(3):307-13. PubMed ID: 6279411
    [Abstract] [Full Text] [Related]

  • 5. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock.
    Hock CE, Su JY, Lefer AM.
    Am J Physiol; 1984 Feb 12; 246(2 Pt 2):H174-9. PubMed ID: 6696129
    [Abstract] [Full Text] [Related]

  • 6. Preservation of cellular integrity as a protective mechanism of dexamethasone in hemorrhagic shock in the cat.
    Trachte GJ, Lefer AM.
    Arch Int Pharmacodyn Ther; 1978 Apr 12; 232(2):309-20. PubMed ID: 677964
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
    Bitterman H, Yanagisawa A, Lefer AM.
    Circ Shock; 1986 Apr 12; 20(1):1-11. PubMed ID: 2945667
    [Abstract] [Full Text] [Related]

  • 9. Salutary effects of nitrendipine, a new calcium entry blocker, in hemorrhagic shock.
    Hock CE, Su JY, Lefer AM.
    Eur J Pharmacol; 1984 Jan 13; 97(1-2):37-46. PubMed ID: 6698110
    [Abstract] [Full Text] [Related]

  • 10. Beneficial effect of anisodamine in hemorrhagic shock.
    Su J, Hock CE, Lefer AM.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr 13; 325(4):360-5. PubMed ID: 6728045
    [Abstract] [Full Text] [Related]

  • 11. Anti-shock actions of a new converting enzyme inhibitor, enalaprilic acid, in hemorrhagic shock in cats.
    Freeman JG, Hock CE, Edmonds JS, Lefer AM.
    J Pharmacol Exp Ther; 1984 Dec 13; 231(3):610-5. PubMed ID: 6094795
    [Abstract] [Full Text] [Related]

  • 12. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
    Bitterman H, Smith BA, Lefer AM.
    Circ Shock; 1988 Mar 13; 24(3):159-68. PubMed ID: 3383353
    [Abstract] [Full Text] [Related]

  • 13. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
    Zingarelli B, Squadrito F, Bussolino F, Calapai G, Altavilla D, Ioculano M, Campo GM, Canale P, Caputi AP.
    J Lipid Mediat Cell Signal; 1994 Mar 13; 9(2):123-34. PubMed ID: 8012759
    [Abstract] [Full Text] [Related]

  • 14. Peripheral effects of opiate antagonists in shock.
    Lefer AM, Curtis MT.
    Adv Shock Res; 1983 Mar 13; 10():83-6. PubMed ID: 6308976
    [No Abstract] [Full Text] [Related]

  • 15. Effect of angiotensin II receptor blockade by [Sar1-Ala8]angiotensin II in hemorrhagic shock.
    Trachte GJ, Lefer AM.
    Am J Physiol; 1979 Feb 13; 236(2):H280-5. PubMed ID: 311160
    [Abstract] [Full Text] [Related]

  • 16. Actions of non-cardiodepressant beta-adrenergic blocking agents in hemorrhagic shock.
    Lefer AM, Lefer DJ, Levin RJ.
    Adv Shock Res; 1980 Feb 13; 3():167-74. PubMed ID: 6118024
    [Abstract] [Full Text] [Related]

  • 17. Protective actions of naloxone in hemorrhagic shock.
    Curtis MT, Lefer AM.
    Am J Physiol; 1980 Sep 13; 239(3):H416-21. PubMed ID: 7435587
    [Abstract] [Full Text] [Related]

  • 18. Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.
    Bitterman H, Phillips GR, Dragon G, Lefer AM.
    J Pharmacol Exp Ther; 1987 Jul 13; 242(1):8-14. PubMed ID: 3039116
    [Abstract] [Full Text] [Related]

  • 19. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock.
    Stahl GL, Bitterman H, Terashita Z, Lefer AM.
    Eur J Pharmacol; 1988 May 10; 149(3):233-40. PubMed ID: 3409951
    [Abstract] [Full Text] [Related]

  • 20. Influence of dopamine on liver dynamics in hemorrhagic shock.
    Trachte GJ, Lefer AM.
    Circ Shock; 1977 May 10; 4(4):305-15. PubMed ID: 598004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.